drugset / Trial / NCT02740933

Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors

NCT02740933

Phase 1 Unknown 40 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

This research study is studying a drug called Demeclocycline that may help brain surgeons see tumors with a microscope during surgery.

Timeline

Start
2016-04
Primary completion
2019-01
Completion
2021-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Demeclocycline Small molecule 300 mg Oral

Indications